These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 19173743

  • 21. Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial.
    Schönenberg M, Wiedemann E, Schneidt A, Scheeff J, Logemann A, Keune PM, Hautzinger M.
    Lancet Psychiatry; 2017 Sep; 4(9):673-684. PubMed ID: 28803030
    [Abstract] [Full Text] [Related]

  • 22. Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury--a pilot study.
    Nikles CJ, McKinlay L, Mitchell GK, Carmont SA, Senior HE, Waugh MC, Epps A, Schluter PJ, Lloyd OT.
    Trials; 2014 Feb 13; 15():54. PubMed ID: 24524676
    [Abstract] [Full Text] [Related]

  • 23. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH, Nagy P, Childress AC, Frick G, Yan B, Pliszka S.
    CNS Drugs; 2017 Nov 13; 31(11):999-1014. PubMed ID: 28980198
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
    Weisler RH, Greenbaum M, Arnold V, Yu M, Yan B, Jaffee M, Robertson B.
    CNS Drugs; 2017 Aug 13; 31(8):685-697. PubMed ID: 28712074
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial.
    Dehbozorghi S, Bagheri S, Moradi K, Shokraee K, Mohammadi MR, Akhondzadeh S.
    Psychiatry Clin Neurosci; 2019 Nov 13; 73(11):690-696. PubMed ID: 31294924
    [Abstract] [Full Text] [Related]

  • 26. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.
    Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM.
    J Clin Psychiatry; 2010 Dec 13; 71(12):1680-8. PubMed ID: 20492837
    [Abstract] [Full Text] [Related]

  • 27. Protocol investigating the clinical utility of an objective measure of attention, impulsivity and activity (QbTest) for optimising medication management in children and young people with ADHD 'QbTest Utility for Optimising Treatment in ADHD' (QUOTA): a feasibility randomised controlled trial.
    Hall CL, James M, Brown S, Martin JL, Brown N, Selby K, Clarke J, Vijayan H, Guo B, Sayal K, Hollis C, Groom MJ.
    BMJ Open; 2018 Feb 15; 8(2):e021104. PubMed ID: 29453304
    [Abstract] [Full Text] [Related]

  • 28. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J.
    Clin Ther; 2009 Jan 15; 31(1):142-76. PubMed ID: 19243715
    [Abstract] [Full Text] [Related]

  • 29. Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
    Philipsen A, Jans T, Graf E, Matthies S, Borel P, Colla M, Gentschow L, Langner D, Jacob C, Groß-Lesch S, Sobanski E, Alm B, Schumacher-Stien M, Roesler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Heinrich V, Huss M, Kornmann C, Bürger A, Perlov E, Ihorst G, Schlander M, Berger M, Tebartz van Elst L, Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS) Consortium.
    JAMA Psychiatry; 2015 Dec 15; 72(12):1199-210. PubMed ID: 26536057
    [Abstract] [Full Text] [Related]

  • 30. [The clinical semiology of attention deficit hyperactivity disorder according to age, and the effectiveness of treatments at different ages].
    García-Pérez A, Expósito-Torrejón J, Martínez-Granero MA, Quintanar-Rioja A, Bonet-Serra B.
    Rev Neurol; 2015 Dec 15; 41(9):517-24. PubMed ID: 16254857
    [Abstract] [Full Text] [Related]

  • 31. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM, Earls MF.
    Pediatrics; 2005 Jan 15; 115(1):e97-104. PubMed ID: 15629972
    [Abstract] [Full Text] [Related]

  • 32. Individualised stepwise adaptive treatment for 3-6-year-old preschool children impaired by attention-deficit/hyperactivity disorder (ESCApreschool): study protocol of an adaptive intervention study including two randomised controlled trials within the consortium ESCAlife.
    Becker K, Banaschewski T, Brandeis D, Dose C, Hautmann C, Holtmann M, Jans T, Jendreizik L, Jenkner C, John K, Ketter J, Millenet S, Pauli-Pott U, Renner T, Romanos M, Treier AK, von Wirth E, Wermter AK, Döpfner M.
    Trials; 2020 Jan 09; 21(1):56. PubMed ID: 31918739
    [Abstract] [Full Text] [Related]

  • 33. [Attention deficit disorder: multidisciplinary observational study over 1 year].
    Chambry J, Billard C, Guinard M, Lacaze E, Idiart ME, Delteil-Pinton F, Cohen de Lara A.
    Encephale; 2011 Jun 09; 37(3):180-90. PubMed ID: 21703433
    [Abstract] [Full Text] [Related]

  • 34. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S, Mohammadi MR, Khademi M.
    BMC Psychiatry; 2004 Apr 08; 4():9. PubMed ID: 15070418
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder.
    Sallee FR, Kollins SH, Wigal TL.
    J Child Adolesc Psychopharmacol; 2012 Jun 08; 22(3):206-14. PubMed ID: 22612526
    [Abstract] [Full Text] [Related]

  • 36. A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.
    Brams M, Muniz R, Childress A, Giblin J, Mao A, Turnbow J, Borrello M, McCague K, Lopez FA, Silva R.
    CNS Drugs; 2008 Jun 08; 22(8):693-704. PubMed ID: 18601306
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness and cost-effectiveness of a brief school-based group programme for parents of children at risk of ADHD: a cluster randomised controlled trial.
    Sayal K, Taylor JA, Valentine A, Guo B, Sampson CJ, Sellman E, James M, Hollis C, Daley D.
    Child Care Health Dev; 2016 Jul 08; 42(4):521-33. PubMed ID: 27272608
    [Abstract] [Full Text] [Related]

  • 38. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY, Pan YL, Lin HY, Huang LW, Gau SS.
    J Child Adolesc Psychopharmacol; 2015 Sep 08; 25(7):566-73. PubMed ID: 26222447
    [Abstract] [Full Text] [Related]

  • 39. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial.
    Frei H, Everts R, von Ammon K, Kaufmann F, Walther D, Hsu-Schmitz SF, Collenberg M, Fuhrer K, Hassink R, Steinlin M, Thurneysen A.
    Eur J Pediatr; 2005 Dec 08; 164(12):758-67. PubMed ID: 16047154
    [Abstract] [Full Text] [Related]

  • 40. Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.
    Adler LA, Dirks B, Deas PF, Raychaudhuri A, Dauphin MR, Lasser RA, Weisler RH.
    J Clin Psychiatry; 2013 Jul 08; 74(7):694-702. PubMed ID: 23945447
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.